Overview

Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether application of low dose Delta9-Tetrahydrocannabinol can prevent the development of chronic pain in patients with acute CRPS.
Phase:
Phase 2
Details
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborators:
German Federal Ministry of Education and Research
German Research Network on Neuropathic Pain
Treatments:
Dronabinol